INS and metabolic dysfunction-associated steatohepatitis: Both noncirrhotic NASH and cirrhotic NASH patients were insulin resistant as indicated by homeostatic model assessment for insulin resistance but the cirrhotic NASH displayed higher levels of circulating insulin (Table 1).